-
-
-
-
-
-
-
MannKind (MNKD) PT Raised to $9 at Leerink Partners
-
-
-
-
-
-
-
MannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a Patient-Centric Leader in Cardiometabolic and Lung Diseases
-
-
-
-
-
-
-
MannKind Corporation Reports 2023 Fourth Quarter and Full Year Financial Results: Provides Clinical Development Update
-
-
-
-
-
-
-
MannKind Corporation Reports 2022 Fourth Quarter and Full Year Financial Results
-
-
-
-
-
-
-
MannKind Corporation Reports 2021 Fourth Quarter and Full Year Financial Results
-
-
-
-
-
-
-
MannKind (MNKD) Repays Maturing Debt Obligation; Buys Back Certain Warrants
-
-
-
-
-
-
-
Pre-Open Movers 09/04: (MNKD) (REPH) (ORIG) Higher; (TAHO) (EYEG) (NKE) Lower (more...)
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

